Experienced Recruitment Consultants and Trainers who have also enjoyed success at a senior level in the Science and Technology markets using their knowledge and extensive networks to help you with:
Recruitment: Board Level to first line Managers and senior specialists in Sales, Service, Applications, Marketing, Business Development, R&D, Manufacturing, Licensing, QA & Regulatory, Clinical, Medical
Sales Training: Tailored in house and open programmes for new hires to senior Managers in Sales, Marketing, Service and Applications Support
Performance Coaching: One to one development for Sales Directors and Sales Managers
HR Services: Outplacement, Retention Strategies, Succession Planning, Performance Management and Career Development
Corporate Development: Fundraising, Mergers, Disposals, Acquisitions. Licensing, and Joint Ventures
Market expertise in Pharmaceutical, Biotechnology, Medical Devices, Diagnostics, Scientific Instrumentation, Scientific Software, Scientific Services.Read more
We seek to find the best science and technology, no matter where it is, to solve the greatest unmet needs of our time. We catalyze, support, and invest in highly differentiated early-stage innovations that will turn into products that extend and improve lives everywhere. At the same time, we seek to nurture the global innovation ecosystem to ensure its continued vibrancy.
Our Innovation Centers—located in Boston, California, London and Shanghai—are Johnson & Johnson Innovation regional hubs, created to access the best science and technology in the region, and also to meet the needs of entrepreneurs and scientists developing important medical device and diagnostic technologies, consumer healthcare products, and pharmaceuticals.
Through our Centers, the exchange of and support for new ideas occurs, which is critical to advancing important products. We have a fully integrated team of scientific and business experts and flexible deal-making capabilities to meet the needs of any company. We bring a strong history of success in R&D, product development, and commercialization to each conversation. We also know first hand how hard, but also how rewarding it is to advance transformative technologies.Read more
KISS is the integrated creative agency that clarifies the complex. We work with the organisations that are changing the world, putting customer experience at the heart of our strategy, creativity and activation capability.Read more
MedCity is a collaboration between the Mayor of London and the capital’s three Academic Health Science Centres – Imperial College Academic Health Science Centre, King’s Health Partners, and UCL Partners
Launched in April 2014 to promote and grow the world-leading life sciences cluster of England’s greater south east, it is promoting life sciences investment, entrepreneurship and industry in the region by:
– Providing a single front door and concierge service for industry and investors looking for partners, infrastructure and expertise
– Facilitating and supporting collaboration across all parts of the sector to turn innovations into commercial products and services
– Fostering an environment that supports and encourages entrepreneurialism
– Raising awareness globally of the region’s rich life sciences ecosystem
It is supported by the Higher Education Funding Council for England and the Mayor of London, and works with the region’s academic, research and NHS institutions, as well as local enterprise partnerships and the Mayor’s official promotional organisation London & Partners.
Over the next 20 years, MedCity will position the greater south east of England as a world-leading, interconnected region for life sciences research, development, manufacturing and commercialisation to stimulate greater economic growth.Read more
Astellas’ raison d’être is to “contribute toward improving the health of people around the world through the provision of innovative and reliable pharmaceutical products.”
Based on this, we aim to stand on the forefront of healthcare change, turning innovative science into value for patients. The keys to our success will be our Focus Areas, Principles of Activity, and Drivers, which describe where we should create value and how we should act to realize that value. Guided by this approach, we will create innovation with a central focus on the innovative drug business.
This process originates with advances in science, and Astellas then allocates sufficient funds and implements measures to satisfy the requests and expectations of stakeholders. By creating value for patients, through this process, we will generate funds to sustain the next phase of growth and provide returns to stakeholders.
Astellas will continue to follow this cycle to achieve sustainable growth of corporate value.
Penningtons Manches LLP is a leading UK law firm which provides high quality legal advice tailored to both businesses and individuals. We address the specific objectives of each client through our flair and technical expertise and offer a personal service founded on a strong team ethic.
Today, we have UK offices in the City of London, Basingstoke, Cambridge, Guildford, Oxford and Reading, with 110 partners and over 600 people in total. We have also established a presence in San Francisco. Our main areas of practice are dispute resolution, corporate and commercial, real estate, private client and family.
We have several multi-disciplinary teams concentrating on a variety of industry sectors, including technology, life sciences, education, social housing, retail and international wealth. In these areas, we’re acknowledged for our unparalleled market insight.
Immunocore is a world leading T cell receptor (TCR) company, a global biotech striving to transform medical practice in the most challenging disease areas. At Immunocore we are focused on delivering first-in-class biological therapies to patients, using our highly innovative soluble TCR platform, and ImmTAC® molecules, a new class of precision-engineered drugs with ultra-high affinity for intracellular cancer targets. ImmTAC molecules naturally recognise cancer cells and cause their destruction through re-directing and activating the patient’s own immune system. This novel class of immunotherapy has the potential to treat a broad spectrum of diseases with high unmet medical need, not only cancers, but also infectious diseases and autoimmune diseases.Read more
With strategically placed offices in the South of England, membership of Kreston International and a global network of independent accountants and business advisers, James Cowper Kreston is ideally placed to provide informed local, national and international advice.
An integrated approach lies at the very heart of our business ethos. We consider all the angles when it comes to providing the widest levels of help, service and support for our clients, and apply the same approach to our people. We believe that a constructive work environment ultimately benefits everyone involved, including you.
This joined-up thinking extends beyond our own walls to the wider financial community. Our membership of Kreston International means that we’re well placed to help with overseas or inward investment.
Whatever your accounting or business advisory needs, our specialist teams work together on your behalf, placing a high value on sound communication. We understand the factors helping and hindering your immediate and long-term aspirations, and our shared vision is to help you succeed.
Marks & Clerk are committed to providing exceptional intellectual
property advice around the world, helping you to navigate the
complexities of IP, patents, trade marks and design protection.
Innovation is the life-blood of business and it’s vital that you do
not overlook the need to protect your intellectual property. From the
capture of an idea, to the enforcement or defence of rights in disputes
Marks & Clerk is your expert partner to ensure your IP is protected and
fully exploited. Today’s local is tomorrow’s global – and with our
diverse team of practitioners, you’re always supported by a network of
Create an engaging plan for your next Group Travel. Planify saves you time and removes the complexity of gathering information from multiple partners as you can see in our Video. Create an up-to-date, changeable and attractive plan to share with your participants.Read more
BenevolentAI was established to build and apply artificial intelligence to humankind’s new natural resource – data, and by doing so unlock science’s ‘hidden knowledge’ and turn highly fragmented unstructured and structured information into new insight and usable knowledge.
Headquartered in London’s Knowledge Quarter, BenevolentAI is focussed on forging a powerful union between humans, technology and science using AI. The Company’s purpose is to dramatically accelerate innovation in industries that rely on science-based ideas, inventions and products and overcome some of the world’s greatest scientific challenges.
BenevolentAI’s initial scientific focus has been in human health, specifically rare disease groups in often overlooked areas. In human health, BenevolentAI has harnessed its technology to make major breakthroughs and accelerate drug development.. The Company has entered into significant license agreements with some of the world’s largest pharmaceutical companies and is beginning its first Phase IIb clinical study in 2017.
BenevolentAI currently operates two distinct business units; ‘BenevolentBio’ which applies BenevolentAI’s technology in human health and the exploration of further bioscience applications, and, ‘BenevolentTech’ which refines and develops the company’s technology and replicates its initial success across wider applications and industries.
Let EMMA help you. We work with busy professionals in fast-growing businesses to ensure that they’re able to focus on the things they really need to. From diary and travel management through to event management, creative design and marketing support, EMMA’s experienced and multi-skilled management assistants can help support you.Read more
IBM is a global cloud platform and cognitive solutions company, which has continually evolved over the past century to remain at the forefront of technological innovation. Our capabilities in data and analytics, cloud, mobile, social and security have helped the UK evolve to become one of the world’s most digitally advanced nations. This digital revolution empowers us and our clients to gather and analyse data in ways that have never been possible before—helping UK organisations unlock new insights and usher in a new era of cognitive business.Read more
Innovate UK is part of UK Research and Innovation, a non-departmental public body funded by a grant-in-aid from the UK government. We drive productivity and economic growth by supporting businesses to develop and realise the potential of new ideas, including those from the UK’s world-class research base.
We’re an organisation of around 300 staff, drawn mainly from business. We work across the UK, with a head office in Swindon.
With a strong business focus, we drive growth by working with companies to de-risk, enable and support innovation.Read more
A Powerful Platform for the Isolation of Fully-human Monoclonal Antibodies.
Genetically engineered mice now act as robust engines for the generation of diverse repertoires of affinity-matured, fully-human variable regions with intrinsic drug-like properties necessary for successful development including high potency, specificity, manufacturability, solubility and low risk of immunogenicity. Few existing or contemplated human transgenic mouse platforms express a full human antibody repertoire. Our lead technology, The Trianni Mouse is the only one to do so in a single organism.